Growing community of inventors

Copenhagen, Denmark

Claus Aagaard

Average Co-Inventor Count = 3.30

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Claus AagaardPeter Andersen (8 patents)Claus AagaardCarina Vingsbo-Lundberg (4 patents)Claus AagaardIda Rosenkrands (3 patents)Claus AagaardJes Dietrich (3 patents)Claus AagaardTruc Thi Kim Thanh Hoang (2 patents)Claus AagaardElse Marie Agger (1 patent)Claus AagaardPeter Lawætz Andersen (1 patent)Claus AagaardSøren Tetens Hoff (1 patent)Claus AagaardPeter Anderson (1 patent)Claus AagaardClaus Aagaard (10 patents)Peter AndersenPeter Andersen (28 patents)Carina Vingsbo-LundbergCarina Vingsbo-Lundberg (4 patents)Ida RosenkrandsIda Rosenkrands (9 patents)Jes DietrichJes Dietrich (5 patents)Truc Thi Kim Thanh HoangTruc Thi Kim Thanh Hoang (2 patents)Else Marie AggerElse Marie Agger (3 patents)Peter Lawætz AndersenPeter Lawætz Andersen (2 patents)Søren Tetens HoffSøren Tetens Hoff (1 patent)Peter AndersonPeter Anderson (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Statens Serum Institut (10 from 53 patents)


10 patents:

1. 10641770 - Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis

2. 10004793 - M.tuberculosis vaccines

3. RE46583 - Vaccines comprising TB10.4

4. 9526773 - [object Object]

5. 8703151 - Tuberculosis vaccines comprising antigens expressed during the latent infection phase

6. 8557258 - Vaccines comprising TB10.4

7. 8293250 - Tuberculosis vaccines comprising antigens expressed during the latent infection phase

8. 8105614 - Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails

9. 8101193 - Tuberculosis vaccines comprising antigens expressed during the latent infection phase

10. 7968105 - Tuberculosis vaccines comprising antigens expressed during the latent infection phase

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…